Skip to content
Contact Us
Webinar - On Demand

Methods to Reliably Monitor Treg Cells in Clinical Studies: Characterizing a Central Switch of Immune Suppression

Date: October 12, 2022

Duration: 51 Minutes

Regulatory T (Treg) cells are a crucial cell type of immune suppression and relevant in a wide range of disease indications. Reliable monitoring in clinical trials has challenges and different technology solutions have been developed including flow cytometry as well as epigenetic immune monitoring (Epiontis ID).
 
In this webinar we will outline the discovery of Treg cells and their role in the immune system. Using several case studies in autoimmune disease, cancer and a Treg-related rare disease called IPEX we will present established solutions that allow reliable monitoring of Treg cells in blood and tissue samples in clinical trials.



Topics covered:

  • Discovery of Tregs and the major role of Treg cells in the immune system
     
  • Historic challenges in monitoring Tregs
     
  • Optimized methods for monitoring Treg cells using a wide range of sample types including blood and tissue
     
  • Case studies of Treg monitoring in autoimmune disease and cancer

Register to Watch Webinar On Demand
Speakers

Uli Hoffmueller

Uli Hoffmueller PhD
Precision for Medicine

Veteran biochemist, industry expert, and cofounder of Epiontis. He holds a Master’s in Biochemistry from Humboldt University, a PhD from the Charité University Clinic, receiving the Charité Research Award, and an MBA from the Berlin School of Economics and Law, Berlin, Germany.

Eva Raschke

Eva Raschke PhD
Precision for Medicine

 Subject matter expert for immune monitoring solutions at Precision for Medicine with a focus on the epigenetic immune monitoring technology Epiontis ID.